248 related articles for article (PubMed ID: 32030498)
21. General practitioners' adherence to chronic heart failure guidelines regarding medication: the GP-HF study.
Hirt MN; Muttardi A; Helms TM; van den Bussche H; Eschenhagen T
Clin Res Cardiol; 2016 May; 105(5):441-50. PubMed ID: 26552905
[TBL] [Abstract][Full Text] [Related]
22. A Stepwise Approach to the Management of Heart Failure and its Comorbidities.
Rogers FJ; Saghir Z
J Am Osteopath Assoc; 2020 Feb; 120(2):90-99. PubMed ID: 31985768
[TBL] [Abstract][Full Text] [Related]
23. Role of Guideline Directed Medical Therapy Doses and Optimization in Patients Hospitalized With Decompensated Systolic Heart Failure.
Grewal D; Partow-Navid R; Garcia D; Coney J; Fraser G; Stoletniy L; Sakr A; Parwani P; Abramov D
Am J Cardiol; 2021 Jul; 151():64-69. PubMed ID: 34167690
[TBL] [Abstract][Full Text] [Related]
24. Pharmacotherapy Treatment Patterns, Outcomes, and Health Resource Utilization Among Patients with Heart Failure with Reduced Ejection Fraction at a U.S. Academic Medical Center.
Bress AP; King JB; Brixner D; Kielhorn A; Patel HK; Maya J; Lee VC; Biskupiak J; Munger M
Pharmacotherapy; 2016 Feb; 36(2):174-86. PubMed ID: 26841333
[TBL] [Abstract][Full Text] [Related]
25. Target Doses of Heart Failure Medical Therapy and Blood Pressure: Insights From the CHAMP-HF Registry.
Peri-Okonny PA; Mi X; Khariton Y; Patel KK; Thomas L; Fonarow GC; Sharma PP; Duffy CI; Albert NM; Butler J; Hernandez AF; McCague K; Williams FB; DeVore AD; Patterson JH; Spertus JA
JACC Heart Fail; 2019 Apr; 7(4):350-358. PubMed ID: 30738978
[TBL] [Abstract][Full Text] [Related]
26. Time to Triple Therapy in Patients With de Novo Heart Failure With Reduced Ejection Fraction: a Population-Based Study.
Sepehrvand N; Nabipoor M; Youngson E; McAlister FA; Ezekowitz JA
J Card Fail; 2023 May; 29(5):719-729. PubMed ID: 36754252
[TBL] [Abstract][Full Text] [Related]
27. Background pharmacological therapy in the ANTHEM-HF: comparison to contemporary trials of novel heart failure therapies.
Premchand RK; Sharma K; Mittal S; Monteiro R; Libbus I; Ardell JL; Gregory DD; KenKnight BH; Amurthur B; DiCarlo LA; Anand IS
ESC Heart Fail; 2019 Oct; 6(5):1052-1056. PubMed ID: 31339232
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of the Usage and Dosing of Guideline-Directed Medical Therapy for Heart Failure With Reduced Ejection Fraction Patients in Clinical Practice.
Smith KV; Dunning JR; Fischer CM; MacLean TE; Bosque-Hamilton JW; Fera LE; Grant JY; Zelle DJ; Matta L; Gaziano TA; MacRae CA; Scirica BM; Desai AS
J Pharm Pract; 2022 Oct; 35(5):747-751. PubMed ID: 33813934
[TBL] [Abstract][Full Text] [Related]
29. Higher versus lower doses of ACE inhibitors, angiotensin-2 receptor blockers and beta-blockers in heart failure with reduced ejection fraction: Systematic review and meta-analysis.
Turgeon RD; Kolber MR; Loewen P; Ellis U; McCormack JP
PLoS One; 2019; 14(2):e0212907. PubMed ID: 30817783
[TBL] [Abstract][Full Text] [Related]
30. Characteristics Associated with Upper-Range Doses of Beta-Blockers and Angiotensin-Renin Inhibitors in Reduced Ejection Fraction.
Itzhaki Ben Zadok O; Murninkas D; Iakobishvili Z; Jino H; Yohananov E; Birkenfeld S; Hasdai D
Isr Med Assoc J; 2020 Jul; 22(7):441-445. PubMed ID: 33236570
[TBL] [Abstract][Full Text] [Related]
31. Combination Therapy of Renin Angiotensin System Inhibitors and β-Blockers in Patients with Heart Failure.
Nochioka K; Sakata Y; Shimokawa H
Adv Exp Med Biol; 2018; 1067():17-30. PubMed ID: 29542073
[TBL] [Abstract][Full Text] [Related]
32. Effects of European Society of Cardiology guidelines on medication profiles after hospitalization for heart failure in 22,476 Dutch patients: from 2001 until 2015.
Kruik-Kollöffel WJ; Linssen GCM; Kruik HJ; Movig KLL; Heintjes EM; van der Palen J
Heart Fail Rev; 2019 Jul; 24(4):499-510. PubMed ID: 30848404
[TBL] [Abstract][Full Text] [Related]
33. Impact of left ventricular ejection fraction on the effect of renin-angiotensin system blockers after an episode of acute heart failure: From the KCHF Registry.
Yoshikawa Y; Tamaki Y; Morimoto T; Yaku H; Yamamoto E; Inuzuka Y; Ozasa N; Kitai T; Nagao K; Sato Y; Kondo H; Tamura T; Nakagawa Y; Kuwahara K; Kato T; Kimura T
PLoS One; 2020; 15(9):e0239100. PubMed ID: 32925953
[TBL] [Abstract][Full Text] [Related]
34. Real-World Analysis of Guideline-Based Therapy After Hospitalization for Heart Failure.
Wirtz HS; Sheer R; Honarpour N; Casebeer AW; Simmons JD; Kurtz CE; Pasquale MK; Globe G
J Am Heart Assoc; 2020 Aug; 9(16):e015042. PubMed ID: 32805181
[TBL] [Abstract][Full Text] [Related]
35. Trends in the Use of Guideline-Directed Therapies Among Dialysis Patients Hospitalized With Systolic Heart Failure: Findings From the American Heart Association Get With The Guidelines-Heart Failure Program.
Pandey A; Golwala H; DeVore AD; Lu D; Madden G; Bhatt DL; Schulte PJ; Heidenreich PA; Yancy CW; Hernandez AF; Fonarow GC
JACC Heart Fail; 2016 Aug; 4(8):649-61. PubMed ID: 27179827
[TBL] [Abstract][Full Text] [Related]
36. The treatment gap in patients with chronic systolic heart failure: a systematic review of evidence-based prescribing in practice.
Chin KL; Skiba M; Tonkin A; Reid CM; Liew D; Krum H; Hopper I
Heart Fail Rev; 2016 Nov; 21(6):675-697. PubMed ID: 27465132
[TBL] [Abstract][Full Text] [Related]
37. Design of a multicentre randomized controlled trial to assess the safety and efficacy of dose titration by specialized nurses in patients with heart failure. ETIFIC study protocol.
Oyanguren J; García-Garrido L; Nebot Margalef M; Lekuona I; Comin-Colet J; Manito N; Roure J; Ruiz Rodriguez P; Enjuanes C; Latorre P; Torcal Laguna J; García-Gutiérrez S;
ESC Heart Fail; 2017 Nov; 4(4):507-519. PubMed ID: 29154427
[TBL] [Abstract][Full Text] [Related]
38. Baseline Characteristics of Patients With Heart Failure and Preserved Ejection Fraction in the PARAGON-HF Trial.
Solomon SD; Rizkala AR; Lefkowitz MP; Shi VC; Gong J; Anavekar N; Anker SD; Arango JL; Arenas JL; Atar D; Ben-Gal T; Boytsov SA; Chen CH; Chopra VK; Cleland J; Comin-Colet J; Duengen HD; Echeverría Correa LE; Filippatos G; Flammer AJ; Galinier M; Godoy A; Goncalvesova E; Janssens S; Katova T; Køber L; Lelonek M; Linssen G; Lund LH; O'Meara E; Merkely B; Milicic D; Oh BH; Perrone SV; Ranjith N; Saito Y; Saraiva JF; Shah S; Seferovic PM; Senni M; Sibulo AS; Sim D; Sweitzer NK; Taurio J; Vinereanu D; Vrtovec B; Widimský J; Yilmaz MB; Zhou J; Zweiker R; Anand IS; Ge J; Lam CSP; Maggioni AP; Martinez F; Packer M; Pfeffer MA; Pieske B; Redfield MM; Rouleau JL; Van Veldhuisen DJ; Zannad F; Zile MR; McMurray JJV
Circ Heart Fail; 2018 Jul; 11(7):e004962. PubMed ID: 29980595
[TBL] [Abstract][Full Text] [Related]
39. Medical Therapy Before, During and After Hospitalization in Medicare Beneficiaries With Heart Failure and Diabetes: Get With The Guidelines - Heart Failure Registry.
Bhatt AS; Fonarow GC; Greene SJ; Holmes DN; Alhanti B; Devore AD; Butler J; Heidenreich PA; Huang JC; Kittleson MM; Linganathan K; Joyntmaddox KE; McDermott JJ; Owens AT; Peterson PN; Solomon SD; Vardeny O; Yancy CW; Vaduganathan M
J Card Fail; 2024 Feb; 30(2):319-328. PubMed ID: 37757995
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of guideline-based cardiovascular medications and their respective doses in heart failure patients in Oman.
Hanbali DA; Hashmi KA; Za'abi MA; Al-Zakwani I
Int J Clin Pharm; 2021 Aug; 43(4):878-883. PubMed ID: 33140296
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
